CONTENTS:
- Cannabis and sport: A World Anti-Doping perspective [Editorial]. Hudzik T.J., Huestis M.A., Rossi S.S., Schumacher Y.O., Harcourt P., Budgett R., et al., p. 2040-2042.
- The effectiveness of workplace interventions for the prevention of alcohol use: A meta-analysis. Fellbaum L., Mojzisch A., Bielefeld L., Benit N., Soellner R., p. 2043-2061.
- The implementation and public health impacts of cannabis legalization in Canada: a systematic review. Hall W., Stjepanovic D., Dawson D., Leung J., p. 2062-2072.
- Commentary on Hall et al.: Evaluating impact of cannabis legalization in Canada-initial outcomes and current trends. Hammond D., p. 2073-2075.
- Systematic review and meta-analysis investigating nicotine, cotinine and carbon monoxide exposures in people who both smoke and use nicotine replacement therapy. Podlasek A., Claire R., Campbell K.A., Orton S., Thomson R., Coleman T., p. 2076-2092.
- Effectiveness of an integrated motivational cognitive-behavioral group intervention for adolescents with gaming disorder: a randomized controlled trial. Ji Y., Wong D.F.K., p. 2093-2104.
- E-cigarette support for smoking cessation: Identifying the effectiveness of intervention components in an on-line randomized optimization experiment. Kimber C., Sideropoulos V., Cox S., Frings D., Naughton F., Brown J., et al., p. 2105-2117.
- Association between job satisfaction and current smoking and change in smoking behavior: a 16-year longitudinal study in South Korea. Baek S.U., Lee W.T., Kim M.S., Lim M.H., Yoon J.H., Won J.U., p. 2118-2127.
- Using a cascade of care framework to identify gaps in access to medications for alcohol use disorder in British Columbia, Canada. Socias M.E., Scheuermeyer F.X., Cui Z., Mok W.Y., Crabtree A., Fairbairn N., et al., p. 2128-2138.
- Commentary on Socias et al.: It is time to be serious about AUD treatment disparities. Karriker-Jaffe K.J., Bensley K.M.K., p. 2139-2140.
- ABC-training as a new intervention for hazardous alcohol drinking: Two proof-of-principle randomized pilot studies. Van Dessel P., Cummins J., Wiers R.W., p. 2141-2155.
- Trends in alcohol-related liver disease mortality in Australia: An age-period-cohort perspective. Livingston M., Room R., Chikritzhs T., Taylor N., Yuen W.S., Dietze P., p. 2156-2163.
- Motivational interviewing and problem-solving therapy intervention for patients on antiretroviral therapy for HIV in Tshwane, South Africa: A randomized controlled trial to assess the impact on alcohol consumption. Parry C.D.H., Myers B., Londani M., Shuper P.A., Janse van Rensburg C., Manda S.O.M., et al., p. 2164-2176.
- Joint effects of substance use disorders and recent substance use on HIV viral non-suppression among people engaged in HIV care in an urban clinic, 2014-2019. Lesko C.R., Falade-Nwulia O.O., Pytell J.D., Hutton H.E., Fojo A.T., Keruly J.C., et al., p. 2193-2202.
- Healthcare costs and use before and after opioid overdose in Veterans Health Administration patients with opioid use disorder. Joyce V.R., Oliva E.M., Garcia C.C., Trafton J., Asch S.M., Wagner T.H., et al., p. 2203-2214.
- The association between longitudinal trends in receipt of buprenorphine for opioid use disorder and buprenorphine-waivered providers in the United States. Stringfellow E.J., Lim T.Y., Dong H., Zhang Z., Jalali M.S., p. 2215-2219.
- Time-varying effect modeling with intensive longitudinal data: Examining dynamic links among craving, affect, self-efficacy and substance use during addiction recovery. Stull S.W., Linden-Carmichael A.N., Scott C.K., Dennis M.L., Lanza S.T., p. 2220-2232.
- Commentary on Stull et al.: Considering person-specific heterogeneity when modeling time-varying trends. Piccirillo M.L., Foster K.T., p. 2233-2234.
- Addiction: A treatise from 1561. Nadeau L., Valleur M., p. 2235-2241.
- How to interpret studies on the impact of legalizing cannabis. Manthey J., Armstrong M.J., Hayer T., Myran D.T., Pacula R.L., Queirolo R., et al., p. 2242-2243.